Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May-Jun;45(3):449-458.
doi: 10.1590/S1677-5538.IBJU.2018.0798.

Second brazilian consensus on the treatment of advanced prostate cancer - a SBOC-SBU-SBRT panel review

André Deeke Sasse  1 , Rodolfo Borges Dos Reis  2 , Lucas Mendes Nogueira  3 , Fernando Cotait Maluf  4 , Daniel Herchenhorn  5 , Oren Smaletz  6 , Volney Soares Lima  7 , Fábio Schutz  4 , Diogo Bastos  8 , Evanius Garcia Wiermann  9 , Igor Alexandre Protzner Morbeck  10 , Leonardo Fontes Jardim  8 , Vinicius Carrera Souza  9 , Icaro Thiago Carvalho  6 , Elton Trigo Teixeira Leite  11 , Archimedes Nardozza Jr  12 , Antonio Carlos Lima Pompeo  13 , Francisco Bretas  14 , Marcos Lima de Oliveira Leal  15 , Marcus Vinicius Sadi  12 , José Ricardo Tuma da Ponte  16 , Gustavo F Carvalhal  17
Affiliations

Second brazilian consensus on the treatment of advanced prostate cancer - a SBOC-SBU-SBRT panel review

André Deeke Sasse et al. Int Braz J Urol. 2019 May-Jun.

Abstract

Prostate cancer is the second most common cancer and the fi fth leading cause of cancer deaths. In Brazil, it is likewise the second most common cancer among men, second only to non-melanoma skin cancers. The aim of this consensus is to align different opinions and interpretations of the medical literature in a practical and patient-oriented approach. The fi rst Brazilian Consensus on the Treatment of Advanced Prostate Cancer was published in 2017, with the goal of reducing the heterogeneity of therapeutic conduct in Brazilian patients with metastatic prostate cancer. We acknowledge that in Brazil the incorporation of different technologies is a big challenge, especially in the Sistema Único de Saúde (SUS), which allows for the disparity in the options available to patients treated in different institutions. In order to update the recommendations and to make them objective and easily accessible, once more a panel of specialists was formed in order to discuss and elaborate a new Brazilian Consensus on Advanced Prostate Cancer. This Consensus was written through a joint initiative of the Brazilian Society of Clinical Oncology (SBOC) and the Brazilian Society of Urology (SBU) to support the clinical decisions of physicians and other health professionals involved in the care of patients with prostate cancer.

Keywords: Consensus; Prostatic Neoplasms; Therapeutics.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1. Summary of all results of the voting process, with or without consensus.
Figure 1
Figure 1. Summary of all results of the voting process, with or without consensus.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sasse AD, Wiermann EG, Herchenhorn D, Bastos DA, Schutz FA, Maluf FC, et al. First Brazilian Consensus of Advanced Prostate Cancer: Recommendations for Clinical Practice. Int Braz J Urol. 2017;43:407–415. - PMC - PubMed
    1. INCA. Instituto Nacional do Câncer. Estimativa 2018: Incidência de Câncer no Brasil. 2018. Accessed on 10/jul/2018, 2018. Available at. < https://www.inca.gov.br/publicacoes/livros/estimativa-2018-incidencia-de...>.
    1. Global Burden of Disease Cancer Collaboration. Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2018;4:1553–1568. - PMC - PubMed
    1. Loblaw DA, Prestrud AA, Somerfield MR, Oliver TK, Brouwers MC, Nam RK, et al. American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology. J Clin Oncol. 2012;30:3136–3140. - PubMed
    1. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin. 1972;22:232–240. - PubMed

Substances